Rutgers, The State University of NJ donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 10 750,000 1,080,262 95,257 95,257 100,000 100,000 100,000 750,000 757,376 1,511,333 2,132,238 2,518,838 2,737,574
Global health 10 750,000 1,080,262 95,257 95,257 100,000 100,000 100,000 750,000 757,376 1,511,333 2,132,238 2,518,838 2,737,574

Donation amounts by donor and year for donee Rutgers, The State University of NJ

Donor Total 2017 2016 2013 2012 2011 2010 2009
Bill and Melinda Gates Foundation (filter this donee) 10,802,616.00 1,511,333.00 4,869,812.00 852,633.00 2,518,838.00 850,000.00 100,000.00 100,000.00
Total 10,802,616.00 1,511,333.00 4,869,812.00 852,633.00 2,518,838.00 850,000.00 100,000.00 100,000.00

Full list of donations in reverse chronological order (10 donations)

DonorAmount (current USD)Amount rank (out of 10)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation1,511,333.0042017-08-04Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to characterize the penetration and distribution of new TB drug candidates in the lung to guide the selection of optimal regimens for the treatment of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,132,238.0032016-09-02Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to test the efficacy of host directed therapy on sterilizing Mtb (Mycobacterium TB) during latent infection and preventing reactivation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,737,574.0012016-08-15Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery and development of more effective, faster acting drug regimens for drug sensitive and drug resistant TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation757,376.0052013-07-30Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a rabbit model that mimics the range of human manifestations of pulmonary TB as a platform for evaluating candidate TB vaccines for the ability to induce sterilizing immunity and/or protect against progression to cavitary TB following challeng; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation95,257.00102013-03-27Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a simple methodology that extracts Mycobacterium tuberculosis from sputum samples, enabling future rapid point-of-care tests for tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,518,838.0022012-10-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery of effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease, by integrating plasma and lesion pharmacokinetic profiling of existing drugs, hits, leads, and clinical development candidates.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation750,000.0062011-10-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a simple methodology that extracts Mycobacterium tuberculosis from sputum samples, enabling future rapid point-of-care tests for tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.0072011-10-12Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to engineer strains of bacteria found in the human gut to produce the vitamin A precursor beta-carotene, and test the hypothesis that vitamin A-deficiency could be controlled and promote healthy growth of children; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.0072010-09-29Global health/Reproductive health carehttps://iatiregistry.org/publisher/bmgf-- to evaluate the effectiveness of the natural antimicrobial protein subtilosin to not only treat vaginal infections but also act as a spermicidal agent; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.0072009-02-26Global health/Medical researchhttps://iatiregistry.org/publisher/bmgf-- to develop transgenic tomatoes that express RNAs that targets several relevant viruses. The team will test whether these antiviral RNAs can accumulate in mammals after their ingestion to suppress viral proliferation.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.